Randomized Trialhigh evidence
Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections: A Randomized Controlled Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·August 20, 2026·PMID 42619534
Why it mattersDelays in appropriate antimicrobial therapy for bloodstream infections are associated with worse outcomes. Rapid molecular diagnostics can shorten time to targeted therapy, potentially reducing complications like persistent infection. This trial provides high-level evidence that multiplex PCR, combined with stewardship, accelerates effective antimicrobial modification across diverse clinical settings.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled